Search clinical trials for: gevokizumab open-label
Total 2482 results
-
XOMA (US) LLCTerminatedPyoderma GangrenosumUnited States
-
XOMA (US) LLCTerminatedPyoderma GangrenosumUnited States, Australia, Canada
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH); Harvard UniversityCompletedMajor Depressive DisorderUnited States
-
Mayo ClinicCompleted
-
PfizerPfizerRecruitingSickle Cell DiseaseUnited States, Nigeria
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Leiden UniversityCompleted
-
University of NebraskaRecruiting
-
Scion NeuroStimEnrolling by invitationParkinson Disease | Parkinson's Disease and ParkinsonismUnited States
-
AI Therapeutics, Inc.CompletedAcute Myeloid Leukemia | OncologyUnited States
-
University of California, San FranciscoRecruiting
-
Alector Inc.Active, not recruitingFrontotemporal DementiaSpain, United States, Portugal, United Kingdom, France, Germany, Netherlands, Belgium, Australia, Italy, Turkey, Switzerland, Argentina, Canada, Greece, Sweden
-
Georgetown UniversityHackensack Meridian Health; Karyopharm Therapeutics IncTerminatedThymoma | Advanced Thymic Epithelial TumorUnited States
-
University Hospital, BordeauxNot yet recruitingBenign Prostatic Hypertrophy | Holmium Laser Enucleation of the Prostate
-
Institut de Recherches Internationales ServierTerminatedChronic UveitisItaly, United Kingdom, Korea, Republic of, Portugal, Taiwan, Australia, Turkey, Tunisia, Austria, France, Germany, Greece, Spain
-
Studio Osteopatico Busto ArsizioRecruiting
-
University of Maryland, BaltimoreNot yet recruitingChronic Pain | Headache
-
Aldeyra Therapeutics, Inc.Recruiting
-
Novartis PharmaceuticalsCompleted
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedFood HypersensitivityUnited States
-
Hospital de Egas MonizCompleted
-
MEI Pharma, Inc.SCRI Development Innovations, LLCCompleted
-
University of California, Los AngelesEnrolling by invitation
-
MEI Pharma, Inc.SCRI Development Innovations, LLCCompleted
-
National Eye Institute (NEI)The Emmes Company, LLCCompleted
-
ES Therapeutics Australia Pty LtdRecruitingDrug Resistant EpilepsyAustralia
-
Menoufia UniversityNot yet recruiting
-
Krystal Biotech, Inc.CompletedDystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis Bullosa | DEB - Dystrophic Epidermolysis BullosaUnited States
-
Protagonist Therapeutics, Inc.Enrolling by invitationPolycythemia VeraUnited States
-
SunovionCompleted
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate-severe Glabellar Lines
-
University of North Carolina, Chapel HillThe Broad Foundation; Crohn's and Colitis Foundation; OpenBiomeTerminated
-
XOMA (US) LLCInstitut de Recherches Internationales ServierTerminatedUveitisUnited States, France, Germany, Poland, United Kingdom, China, Spain, Mexico, Portugal, Turkey, Israel, Canada, South Africa, Taiwan, Argentina, Russian Federation, Australia, Italy, Brazil, Armenia, Greece, Tunisia
-
M.D. Anderson Cancer CenterRecruitingFatigue | Metastatic CancersUnited States
-
Matthew C. BakerWithdrawnPrimary Sjogren's SyndromeUnited States
-
XOMA (US) LLCInstitut de Recherches Internationales ServierTerminatedUveitisUnited States, France, Germany, Poland, United Kingdom, China, Spain, Mexico, Portugal, Turkey, Israel, Korea, Republic of, South Africa, Taiwan, Argentina, Brazil, Austria, Russian Federation, Australia, Armenia, Greece, Tunisia
-
University of California, DavisActive, not recruitingAttitude | IntentionUnited States
-
Vanda PharmaceuticalsRecruitingGastroparesis | Diabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
University of PennsylvaniaTerminated
-
University of ArkansasCompleted
-
Michigan State UniversityUniversity of Wisconsin, MadisonCompleted
-
Opsidio, LLCInnovaderm Research Inc.RecruitingAtopic DermatitisUnited States, Canada
-
Sanifit Therapeutics S. A.CompletedCalciphylaxis | Calcific Uremic ArteriolopathyUnited States, Belgium, United Kingdom, Spain, Germany, Poland
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingDepression | Quality of Life | End Stage Renal Disease | Disability PhysicalUnited States
-
Stanford UniversityCompletedTreatment Resistant DepressionUnited States
-
Stealth BioTherapeutics Inc.TerminatedPrimary Mitochondrial MyopathyUnited States, Germany, Canada, Italy, United Kingdom, Denmark, Hungary
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End Stage Kidney DiseaseUnited States, Bulgaria, Portugal, Spain, Poland, Serbia
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)United States, Bulgaria, Portugal, Spain, Poland, Serbia
-
Johns Hopkins UniversityNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsCompletedDepression | Quality of Life | Caregiver Burden | Mild Cognitive Impairment | Disability Physical | Dementia, Mild | Impairment, CognitiveUnited States
-
Fiechtner, Justus J., M.D., P.C.MallinckrodtUnknownPsoriatic ArthritisUnited States